Application 203844

Type: ANDA
Sponsor: CADILA PHARMS LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	CAPSULE;ORAL	EQ 1.5MG BASE	No	No
002	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	CAPSULE;ORAL	EQ 3MG BASE	No	No
003	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	CAPSULE;ORAL	EQ 4.5MG BASE	No	No
004	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	CAPSULE;ORAL	EQ 6MG BASE	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A203844-001	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13
A203844-002	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13
A203844-003	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13
A203844-004	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A203844-001	AB
A203844-002	AB
A203844-003	AB
A203844-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203844-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203844-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	AB	2017-02-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203844-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	AB	2017-02-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203844-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	AB	2017-02-13	`d8e5a09893c0…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A203844-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203844-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203844-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203844-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203844-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203844-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203844-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203844-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203844-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203844-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203844-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203844-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203844-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203844-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203844-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203844-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203844-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203844-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203844-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203844-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203844-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203844-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203844-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203844-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203844-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203844-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203844-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203844-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203844-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203844-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203844-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203844-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203844-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203844-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203844-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203844-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203844-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203844-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203844-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203844-004	AB	1	`d8e5a09893c0…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rivastigmine Tartrate	RIVASTIGMINE TARTRATE	Cadila Pharmaceuticals Limited	e7e641fe-39bd-4681-a430-6dedeb6d6af5	2022-12-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203844 application number: ANDA203844 ndc (product): 71209-012 ndc (product): 71209-014 ndc (product): 71209-015 ndc (product): 71209-013
Rivastigmine Tartrate	RIVASTIGMINE TARTRATE	Modavar Pharmaceuticals LLC	209f3b02-0acf-46e9-b355-91c918a20eb3	2022-12-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203844 application number: ANDA203844 ndc (product): 72241-014 ndc (product): 72241-013 ndc (product): 72241-011 ndc (product): 72241-012
RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	83bd2ff6-1d8b-4cac-a37b-fd01dc3f34a1	2022-02-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203844 application number: ANDA203844 ndc (product): 75834-136 ndc (product): 75834-135 ndc (product): 75834-133 ndc (product): 75834-134

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 40 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
71209-012	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-012	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-012	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-012	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-012	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-013	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-013	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-013	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-013	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-013	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-014	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-014	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-014	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-014	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-014	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-015	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-015	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-015	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-015	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
71209-015	Rivastigmine Tartrate	Rivastigmine Tartrate	Cadila Pharmaceuticals Limited	ANDA	Current
72241-011	Rivastigmine Tartrate	Rivastigmine Tartrate	Modavar Pharmaceuticals LLC	ANDA	Current
72241-011	Rivastigmine Tartrate	Rivastigmine Tartrate	Modavar Pharmaceuticals LLC	ANDA	Current
72241-012	Rivastigmine Tartrate	Rivastigmine Tartrate	Modavar Pharmaceuticals LLC	ANDA	Current
72241-012	Rivastigmine Tartrate	Rivastigmine Tartrate	Modavar Pharmaceuticals LLC	ANDA	Current
72241-013	Rivastigmine Tartrate	Rivastigmine Tartrate	Modavar Pharmaceuticals LLC	ANDA	Current
72241-013	Rivastigmine Tartrate	Rivastigmine Tartrate	Modavar Pharmaceuticals LLC	ANDA	Current
72241-014	Rivastigmine Tartrate	Rivastigmine Tartrate	Modavar Pharmaceuticals LLC	ANDA	Current
72241-014	Rivastigmine Tartrate	Rivastigmine Tartrate	Modavar Pharmaceuticals LLC	ANDA	Current
75834-133	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-133	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-133	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-134	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-134	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-134	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-135	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-135	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-135	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-136	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-136	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-136	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	Nivagen Pharmaceuticals, Inc.	ANDA	Current